Dopaminergic neurones: Much more than dopamine?

British Journal of Pharmacology

Volumn 146, Issue 2, 2005, Pages 167-169

  Seutin, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Dopamine transporter; Dopaminergic neurones, colocalization; Serotonin syndrome; Transporters; Vesicular monoamine transporters

Indexed keywords

CANNABINOID; CHOLECYSTOKININ; DOPAMINE; GLUTAMIC ACID; NEUROTENSIN; SEROTONIN;

ARTICLE; BRAIN METABOLISM; COGNITION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; EMOTION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA;

DOPAMINE; DOPAMINE AGENTS; ENDOCANNABINOIDS; GLUTAMIC ACID; HUMANS; NEURONS;

EID: 30544445022     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706328     Document Type: Article

References (32)

1. AGNATI, L. & FUXE, K. (2000). Volume transmission as a key feature of information handling in the central nervous system: possible new interpretative value of the Turing's B-type machine. Prog. Brain. Res., 125, 3-19.
2. BEAN, A.J. & ROTH, R.H. (1991). Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effect of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci., 11, 2694-2702.
3. BERGER, B., GASPAR, P. & VERNEY, C. (1992). Colocalization of neurotensin in the mesocortical dopaminergic system. Restricted regional and laminar distribution in rat, lack of colocalization in human. Ann. NY Acad. Sci., 668, 307-310.
4. BJORKLUND, A. & LINDVALL, O. (1984). Dopamine-containing Systems in the CNS. Amsterdam, New York, Oxford: Elsevier Science Publishers.
5. BOURQUE, M.J. & TRUDEAU, L.E. (2000). GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur. J. Neurosci., 12, 3172-3180.
6. BOYER, E.W. & SHANNON, M. (2005). The serotonin syndrome. N. Engl. J. Med., 353, 1112-1120.
7. CHUHMA, N., ZHANG, H., MASSON, J., ZHUANG, X., SULZER, D., HEN, R. & RAYPORT, S. (2004). Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J. Neurosci., 24, 972-981.
8. CORNIL, C.A., BALTHAZART, J., MOTTE, P., MASSOTTE, L. & SEUTIN, V. (2002). Dopamine activates noradrenergic receptors in the preoptic area. J. Neurosci., 22, 9320-9330.
9. DAHLSTRÖM, A. & FUXE, K. (1964). Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand., 62, 1-55.
10. DAL BO, G., ST-GELAIS, F., DANIK, M., WILLIAMS, S., COTTON, M. & TRUDEAU, L.E. (2004). Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J. Neurochem., 88, 1398-1405.
11. DESCARRIES, L., WATKINS, K.C., GARCIA, S., BOSLER, O. & DOUCET, G. (1996). Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol., 375, 167-186.
12. DIANA, M.A. & MARTY, A. (2004). Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol., 142, 9-19.
13. GRAS, C., HERZOG, E., BELLENCHI, G.C., BERNARD, V., RAVASSARD, P., POHL, M., GASNIER, B., GIROS, B. & EL MESTIKAWY, S. (2002). A third vesicular glutamate transporter expressed by cholinergic and serotonergic neurons. J. Neurosci., 22, 5442-5551.
14. HATTORI, T. (1993). Conceptual history of the nigrostriatal dopamine system. Neurosci. Res., 16, 239-262.
15. HOKFELT, T., REHFELD, J.F., SKIRBOLL, L., IVEMARK, B., GOLDSTEIN, M. & MARKEY, K. (1980). Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature, 285, 476-478.
16. JOHNSON, D.M. (1994). Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron, 12, 433-442.
17. LAVIN, A., NOGUERIA, L., LAPISH, C.C., WIGHTMAN, R.M., PHILLIPS, P.E. & SEAMANS, J.K. (2005). Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J. Neurosci., 25, 5013-5023.
18. MALENKA, R.C. & NICOLL, R.A. (1986). Dopamine decreases the calcium-activated after hyperpolarization in hippocampal CA1 pyramidal cells. Brain Res., 379, 210-215.
19. MELIS, M., PERRA, S., MUNTONI, A.L., PILLOLLA, G., LUTZ, B., MARSICANO, G., DI MARZO, V., GESSA, G.L. & PISTIS, M. (2004). Prefrontal cortex stimulation induces 2-arachidonoylglycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci., 24, 10707-10715.
20. MORON, J.A., BROCKINGTON, A., WISE, R.A., ROCHA, B.A. & HOPE, B.T. (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci., 22, 389-395.
21. PALACIOS, J.M., SAVASTA, M. & MENGOD, G. (1989). Does cholecystokinin colocalize with dopamine in the human substantia nigra? Brain Res., 488, 369-375.
22. RIEGEL, A. & LUPICA, C.R. (2004). Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci., 24, 11070-11078.
23. SAVASTA, M., PALACIOS, J.M. & MENGOD, G. (1990). Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. Mol. Brain Res., 7, 91-104.
24. SCHULTZ, W. & DICKINSON, A. (2000). Neuronal coding of prediction errors. Annu. Rev. Neurosci., 23, 473-500.
25. SEROOGY, K., CECCATELLI, S., SCHALLING, M., HOKFELT, T., FREY, P., WALSH, J., DOCKRAY, G., BROWN, J., BUCHAN, A. & GOLDSTEIN, M. (1988). A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin. Brain Res., 455, 88-98.
26. SHIGERI, Y., SEAL, R.P. & SHIMAMOTO, K. (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev., 45, 250-265.
27. STAMFORD, J.A., KRUK, Z.L. & MILLAR, J. (1990). Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res., 515, 171-180.
28. STORNETTA, R.L., SEVIGNY, C.P. & GUYENET, P.O. (2002). Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons. J. Comp. Neurol., 444, 191-206.
29. SUAREZ-ROCA, H. & CUBEDDU, L.X. (2002). The selective serotonin reuptake inhibitor citalopram induces the storage of serotinin in catecholaminergic terminals. J. Pharmacol. Exp. Ther., 302, 174-179.
30. SULZER, D., JOYCE, M.P., LIN, L., GELDWERT, D., HABER, S.N., HATTORI, T. & RAYPORT, S. (1998). Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci., 18, 4588-4602.
31. TRUDEAU, L.E. (2004). Glutamate co-transmission as an emerging concept in monoamine neuron function. Rev. Psychiatr. Neurosci., 29, 296-310.
32. ZHOU, F.M., LIANG, Y., SALAS, R., ZHANG, L., DE BIASI, M. & DANI, J.S. (2005). Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron, 46, 65-74.